Diagnostic Yield of Chromosomal Microarray Analysis in an Autism Primary Care Practice: Which Guidelines to Implement?
- 877 Downloads
Genetic testing is recommended for patients with ASD; however specific recommendations vary by specialty. American Academy of Pediatrics and American Academy of Neurology guidelines recommend G-banded karyotype and Fragile X DNA. The American College of Medical Genetics recommends Chromosomal Microarray Analysis (CMA). We determined the yield of CMA (N = 85), karyotype (N = 119), and fragile X (N = 174) testing in a primary pediatrics autism practice. We found twenty (24%) patients with abnormal CMA results (eight were clinically significant), three abnormal karyotypes and one Fragile X syndrome. There was no relationship between CMA result and cognitive level, seizures, dysmorphology, congenital malformations or behavior. We conclude that CMA should be the clinical standard in all specialties for first tier genetic testing in ASD.
KeywordsGenetic testing guidelines Chromosomal microarray Karyotype Dysmorphology
The author acknowledges Dan Coury, M.D., Medical Director for The Autism Treatment Network, a program of Autism Speaks, for his support in the idea generation for this work. This research received no financial support.
- Achenbach, T. M., & Rescorla, L. A. (2001a). Manual for the ASEBA pre-school forms and profiles. Burlington: University of Vermont, Research Center for Children, Youth, and Families.Google Scholar
- Achenbach, T. M., & Rescorla, L. A. (2001b). Manual for the ASEBA school-age forms and profiles. Burlington: University of Vermont, Research Center for Children, Youth, and Families.Google Scholar
- American Academy of Neurology (2000). Practice guidelines: Screening and diagnosis of autism. http://www.aan.com/practice/guideline/index.cfm?fuseaction=home.welcome&keywords=autism+Submit=Search+guidelines. Accessed 7/21/2011.
- American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (4th ed, text revision). Washington DC: American Psychiatric Association, (pp. 69–84).Google Scholar
- Barrett, S., Landa, R., Beck, J. C., & Braun, T. A. (1999). An autosomal genomic screen for autism. American Journal of Medical Genetics, 88, 609–615.Google Scholar
- Bayley, N. (1993). Bayley scales of infant development (2nd ed.). San Antonio: Psychological Corporation.Google Scholar
- Burnside, R. D., Pasion, R., Mikhail, F. M., Carroll, A. J., et al. (2011). Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Human Genetics [epub ahead of print].Google Scholar
- Cook, E. H., & Schanen, C. (2008). IDEAS physician advisory. http://www.idic15.org Accessed 5/2011.
- Gilliam, J. E. (2006). Gilliam autism rating scale (2nd ed.). Austin, TX: ProEd.Google Scholar
- Jacquemont, M. L., Sanlaville, D., Redon, R., Raoul, O., et al. (2006). Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. Journal of Medical Genetics, 43(11), 843–849.PubMedCrossRefGoogle Scholar
- Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., et al. (2010). Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 86(5), 749–764.PubMedCrossRefGoogle Scholar
- Mullen, E. M. (1995). Mullen scales of early learning (AGS ed.). Circle Pines: American Guidance Service Inc.Google Scholar
- Phelan, M. C. (2008). Deletion 22q13.3 syndrome. Orphanet Journal of Rare Diseases, 3, 14. doi: 10.1186/1750-1172-3-14.
- Roid, G. H. (2003). The Stanford-Binet intelligence scale (5th ed.). Itasca: Riverside Publishing.Google Scholar
- Ronald, A., & Hoekstra, R. A. (2011). Autism spectrum disorders and autistic traits: A decade of new twin studies. American Journal of Medical Genetics, 156(Part B), 255–274.Google Scholar
- Rosser, J. (2011). Diagnostic yield of genetic testing in children diagnosed with autism spectrum disorders at a regional referral center. Clinical Pediatric. doi: 10.1177/0009922811406261.
- Shen, Y., Dies, K. A., Holm, I. A., Bridgemohan, C., et al. (2010). Autism consortium clinical genetics/DNA diagnostics collaboration. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics, 125(4), e727–e735.Google Scholar
- Sparrow, S., Balla, D., & Cicchetti, D. V. (1984). The Vineland adaptive behavior scales (Survey Form). Circle Pines, MN: American Guidance Service.Google Scholar
- Terman, L. M., & Merrill, M. A. (1972). Stanford-binet intelligence scale (1972 norms ed.). Boston: Houghton Mifflin.Google Scholar
- Thomas, J. A., Johnson, J., Peterson Kraai, T. L., Wilson, R., et al. (2003). Genetic and clinical characterization of patients with an interstitial duplication 15q11–q13, emphasizing behavioral phenotype and response to treatment. American Journal of Medical Genetics, 119A(2), 111–120.PubMedCrossRefGoogle Scholar
- Thorndike, R., Hagen, E., & Sattler, J. (1986). The Stanford-binet intelligence scale (4th ed.). Chicago: Riverside Publishing.Google Scholar
- Wechsler, D. (1989). Wechsler preschool and primary scale of intelligence—Revised. San Antonio: The Psychological Corporation.Google Scholar
- Wechsler, D. (1991). The Wechsler intelligence scale for children (3rd ed.). San Antonio: The Psychological Corporation.Google Scholar
- Wechsler, D. (2004). The Wechsler intelligence scale for children- (4th ed.). London: Pearson Assessment.Google Scholar